NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Exo Therapeutics

Exo Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceswww.exo-therapeutics.com

Last Round

Series B

Oct 5, 2021

Total Funding Raised

$103M

Company Overview

Exo Therapeutics is a biotechnology company focused on drug discovery technology that targets challenging pharmaceutical targets through a pipeline of potent drug candidates that bind to unique exosites, aiming to reprogram enzyme activity for effective therapies while minimizing side effects.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

drug discoverysmall moleculeexositeundruggable targetsbiotechTBK1 inhibitorEXO-TBKicomputational biologyDNA-encoded librariesoncologyinflammatory diseasedrug pipelinepharma partneringstructure-based designrational drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exo Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Exo Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Exo Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 5, 2021
Series ADec 16, 2020

Exo Therapeutics Investors

Notable investors and investment history

Exo Therapeutics investors
InvestorRounds
Newpath PartnersSeries B, Series A
Morningside VenturesSeries B
BVF Partners L.P.Series B
CRVSeries B, Series A
Casdin CapitalSeries B
Nextech InvestSeries B
6 Dimensions CapitalSeries B, Series A

Exo Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exo Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exo Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range16
Year Founded2018
Last FundingOct 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.